DSGN

Conviction 100HealthcareScan · Fri, Jun 26, 2026

Three outside down

DSGN$13.30-1.04%

ResistanceSupportVol 14

Vol MA14 820.91K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Design Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.designtx.com ↗

Price13.30

Change-1.04%

Gap-0.63%

Rel volume2.52×

Avg volume873.81K

Avg $ vol10.13M

SMA 2011.52

SMA 5012.45

SMA 2009.78

Price vs 50+6.87%

Price vs 200+35.95%

MA stackbullish

50/200 cross—

Supertrendup · 11.56

RSI (14)61

MACD hist0.37

MACD crossbull · 9d

Stoch %K / %D71 / 75

ADX (14)21

+DI / −DI32 / 19

RSI divergenceBullish

MACD divergenceBullish

ATR %+6.48%

ADR %5.98%

52w high15.79

52w low3.37

From 52w high-15.77%

Above 52w low+294.66%

New 52w highNo

SqueezeOff

Bollinger width45.36%

%B0.84

Donchian pos72.06%

Donchian high14.63

Donchian low9.87

AVWAP (52w high)12.30

vs AVWAP high+8.09%

AVWAP (52w low)10.34

vs AVWAP low+28.60%

OBV trendFlat

Chaikin MF (20)-0.03

Today vs 20d2.52×

Avg vol (14d)820.91K

Avg vol (20d)873.81K

Avg $ vol (20d)10.13M

Market cap—

RS 3m (vs SPY)+13.46%

RS 6m (vs SPY)+27.72%

RS line new highNo

Trend template8/8

Technical rank85.0

1 week+6.91%

1 month+19.82%

3 months+24.18%

6 months+38.54%

1 year+236.71%

YTD+46.15%

P/E-12.01

P/B3.84

P/S—

P/FCF-15.36

EPS-1.22

Div yield—

ROE-32.01%

ROA-30.29%

Debt/Eq—

Current22.28

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-40.74%

Price target20.75

Target upside54.62%

Analyst ratingBuy

Institutional63.46%

Ent. value825.4M

Revenue20K

Net income-17.64M

Gross profit—

Free cash flow-54.55M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out62.46M

Employees54

ListedFri, Mar 26, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank85.0 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmThree outside down

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DSGN

All disclosures →

No recent disclosed trades by Congress in DSGN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DSGN

No recent insider (Form 4) filings in DSGN. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in DSGN · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.